Grace Therapeutics News

Acasti Pharma | EFFECT: Others

Oct 16, 2024 18:03

Acasti Pharma | EFFECT: Others

Oct 16, 2024 18:03

Acasti Pharma | 424B3: Prospectus

Aug 8, 2024 04:20

Acasti Pharma | EFFECT: Others

Aug 5, 2024 18:07

Acasti Pharma | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Jul 31, 2024 19:26

Acasti Pharma | S-4: Registration of securities issued in business combination transactions

Jun 28, 2024 05:04

Acasti Pharma | EFFECT: Others

Oct 17, 2023 12:15

Acasti Pharma | 424B3: Prospectus

Oct 17, 2023 04:31

Acasti Pharma | 424B3: Prospectus

Jun 24, 2022 04:41

Acasti Pharma | 424B5: Prospectus

Nov 10, 2021 20:23

Acasti Pharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Aug 12, 2021 23:00

Acasti Pharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Aug 5, 2021 05:03

Acasti Pharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Aug 5, 2021 05:00

Acasti Pharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 23, 2021 20:41

Acasti Pharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 22, 2021 05:15

Acasti Pharma | EFFECT: Others

Jul 16, 2021 12:15

Acasti Pharma | 424B3: Prospectus

Jul 16, 2021 04:45

Acasti Pharma | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Jul 14, 2021 04:41

Acasti Pharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 7, 2021 19:08

Acasti Pharma | EFFECT: Others

Jul 8, 2020 12:16